(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced six presentations, including three oral presentations, at the 2025 International HBV Meeting, being held September 8 – 12, 2025 […]

(NASDAQ:SFIX), SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its fourth quarter and full fiscal year 2025 ended August 2, 2025 after market close on Wednesday, September 24, 2025. Following this, Stitch Fix will hold a

(NYSE:DLNG), ATHENS, Greece, Sept. 03, 2025 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (“Dynagas Partners” or the “Partnership”), an owner and operator of LNG carriers, today announced that it will release its financial results for the second quarter and six months ended June 30, 2025 before market opens in New York on Monday,

(NYSE:PFLT),(TASE:PFLT.TA), MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) declares its monthly distribution for September 2025 of $0.1025 per share, payable on October 1, 2025 to stockholders of record as of September 15, 2025. The distribution is expected to be paid from taxable net investment income. The

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes GlobeNewswire September 03, 2025 MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is

Methode Electronics Reschedules First Quarter Fiscal 2026 Earnings Release and Conference Call GlobeNewswire September 03, 2025 CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system and power distribution applications, announced today that it has postponed the release of its financial

Longeveron(R) Announces Key Leadership Updates GlobeNewswire September 03, 2025 Than Powell, Chief Business Officer and head of business development, appointed Interim CEO Dr. Joshua Hare, co-founder and chief science officer, appointed Executive Chairman of the Board of Directors Wa'el Hashad to step down as CEO and Board member National search to occur for permanent CEO

Remitly Announces Upcoming Investor Webinar and Product Event GlobeNewswire September 03, 2025 SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that its management team will present at the following webinar and product event: Remitly Webinar on Product Innovation/StablecoinsDate:

Noodles & Company Announces Review of Strategic Alternatives to Maximize Shareholder Value GlobeNewswire September 03, 2025 BROOMFIELD, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting GlobeNewswire September 03, 2025 SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced six presentations, including three